Company Filing History:
2 out of 535 
2 out of 5,007 
Years Active: 2019-2020
Title: Innovations of Chloe J A Shea in Bacterial Biofilm Research
Introduction
Chloe J A Shea is an accomplished inventor based in Cincinnati, OH (US). She has made significant contributions to the field of bacterial biofilm research, holding 2 patents that focus on innovative screening methods for compounds effective against bacterial biofilms. Her work is crucial in the ongoing battle against bacterial infections that are resistant to conventional treatments.
Latest Patents
Chloe's latest patents include a multi-tiered high-throughput screening method designed to identify agents that inhibit biofilm formation and eradicate established biofilms. This method comprises three tiers, each containing three specific biological process assays. The tier levels consist of a primary screen, a confirmation screen, and a dose-response screen. The biological process assays evaluate total bacterial growth, bacterial metabolic activity, and biofilm formation. Compounds are subjected to a rigorous screening process, advancing through the tiers based on their performance in the assays. This innovative approach has been validated for its effectiveness in identifying agents that can inhibit and kill bacterial biofilms.
Career Highlights
Chloe has worked with notable institutions, including the University of Cincinnati and the United States of America, represented by the Secretary of the Air Force. Her research has been instrumental in developing methods that enhance our understanding of bacterial biofilms and their impact on health.
Collaborations
Chloe has collaborated with esteemed colleagues such as Daniel J Hassett and Thomas J Lamkin. Their combined expertise has contributed to the advancement of research in this critical area.
Conclusion
Chloe J A Shea's innovative work in bacterial biofilm research exemplifies the importance of scientific inquiry in addressing complex health challenges. Her patents and collaborations highlight her commitment to advancing medical science and improving treatment options for bacterial infections.